Sergio Villa Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2021	How to implement the requirements of a quality assurance system for prostate cancer.
1/2018	Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy.
5/2017	Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
11/2012	Contouring variability of the penile bulb on CT images: quantitative assessment using a generalized concordance index.
10/2012	The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
4/2007	Vaccination therapy in prostate cancer.
3/2005	Italian survey in postoperative radiation therapy for prostate carcinoma by the AIRO National Working Group on Prostate Radiotherapy: definitive results.
11/2004	Treatment options in hormone-refractory metastatic prostate carcinoma.
11/2003	External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: age is not a problem.
4/2002	Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio Villa Research Topics

Disease

10	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2002
6	Neoplasms (Cancer) 04/2022 - 07/2013
4	Carcinoma (Carcinomatosis) 09/2011 - 11/2004
2	Rectal Neoplasms (Rectal Cancer) 03/2023 - 12/2020
2	Erectile Dysfunction 11/2012 - 09/2011
1	Margins of Excision 03/2023
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2022
1	Seminoma 04/2022
1	Hypertension (High Blood Pressure) 01/2018
1	Adenocarcinoma 11/2003
1	Cystitis 04/2002
1	Proctitis 04/2002

Drug/Important Bio-Agent (IBA)

3	AndrogensIBA 04/2022 - 11/2004
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 04/2022
1	Testosterone (Sustanon)FDA Link 04/2022
1	AnticoagulantsIBA 01/2018
1	CarbonIBA 05/2017
1	IonsIBA 05/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 07/2013
1	Hormones (Hormone)IBA 11/2004

Therapy/Procedure

9	Radiotherapy 04/2022 - 04/2002
5	Therapeutics 12/2016 - 11/2004
2	Prostatectomy (Retropubic Prostatectomy) 04/2007 - 03/2005
1	Neoadjuvant Therapy 03/2023
1	Orchiectomy (Orchidectomy) 04/2022
1	Adjuvant Radiotherapy 04/2022
1	Castration 01/2021
1	Re-Irradiation 12/2020
1	Drug Therapy (Chemotherapy) 11/2004